Skip to main content

Find Clinical Trials

Home
Conditions
Thymoma

Clinical trial condition

Thymoma

Explore clinical trials studying Thymoma. Study availability and eligibility vary by location and protocol.

41 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Thymoma trial results

Completed

Surgery for Masaoka-Koga I-II Thymoma

NCT05001113

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Masaoka Stage I, +8 more
Locations: Shanghai Zhongshan Hospital Shanghai, China

View Trial Details

Completed

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

NCT03023319

Conditions: Adenoma, Adnexal Diseases, Bladder Cancer, +44 more
Locations: Augusta University Georgia Cancer Center Augusta, Georgia, United States

View Trial Details

Completed

A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas

NCT02220855

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +6 more
Locations: Indiana University Simon Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma

NCT04577495

Conditions: Computed Tomography, Hemic and Lymphatic Diseases, Histology, +10 more
Locations: Not specified

View Trial Details

Completed

The Role of the Thymus in Myasthenia Gravis

NCT01102192

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Hemic and Lymphatic Diseases, +17 more
Locations: Charite University (Dept of Neurology & NeuroCure Clinical Research Center NCRC) Berlin, Germany

View Trial Details

Completed

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

NCT00921739

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma

NCT00198133

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies

NCT01364727

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +8 more
Locations: Stanford University School of Medicine Stanford, California, United States

Indiana University Indianapolis, Indiana, United States

View Trial Details

Completed

Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epithelial Tumors

NCT03288662

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +6 more
Locations: Not specified

View Trial Details

Completed

Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma

NCT00332969

Conditions: Disease, Hemic and Lymphatic Diseases, Lymphatic Diseases, +9 more
Locations: Novartis Investigative Site Regensburg, Germany

View Trial Details